Abstract Tumor necrosis factor (TNF) is a key cytokine across homeostasis, health, and disease. However, the role of TNF is often dichotomous in that it is critical for protective anti-microbial and anti-tumour responses, yet it is also a major player in immune dysfunction and immune-related pathology. Surprisingly, while the effects of TNF on myeloid responses are well studied, how TNF impacts lymphocyte responses is yet to be elucidated. This is particularly the case for natural killer (NK) cells, innate lymphoid cells which play a key role in immune protection against both cancer and infection. To address this knowledge gap, we have generated novel transgenic mouse models which lack the receptors for TNF (TNFR1 and/or TNFR2) specifically on NK cells, allowing us to precisely dissect how TNF directly regulates NK cell function and survival, along with the relative importance of each receptor. Using single cell RNA sequencing among other techniques, we have discovered TNF regulates expression of co-inhibitory receptors on NK cells, including Tim3 and TIGIT, through both TNFR1 and TNFR2. In models of infection and cancer we have found that TNFR1 plays an inhibitory role through depletion of NK cells, leading to increased disease burden. Conversely, TNFR2 plays a protective role through maintenance of optimal NK function and cytokine production, promoting disease control. This ongoing work establishes the importance of TNF in the regulation of NK cell function, which could have significant clinical implications.